Condition: Lipid Metabolism Disorders · Hypertriglyceridemia · Sponsor: The Miriam Hospital
The goal of this study is to learn more about omega-3 polyunsaturated fatty acids supplementation on blood lipid profile and platelets in patients with high cholesterol levels. The purpose of this research is to gather information on the safety and effect of two different fish oils, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Participants will: Visit the clinic 3 times during study checkups, tests and blood collection. Randomized to either the EPA or the DHA supplementation group. Be given a 28-day food and activity log.
This description comes directly from the study's public registry record.
Wenliang Song, MD · 4014449851 · WSong@Lifespan.org
Daria Salamevich · 4014449857 · DSalamevich@Lifespan.org
Always discuss trial participation with your own doctor first.
| Brown University Health - Lipid Clinic | Providence, Rhode Island, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06494488